From the Associated Press (AP), you can go to thei
Post# of 148175
https://apnews.com/
Note they say the following and I wish they would produce their own article which I believe would be more comprehensive:
Quote:
PRESS RELEASES - AP Editors were not involved in the creation of the content below
I have emailed them information after trying to speak with an editor; would love it if they follow through. These would be free articles CytoDyn would not need pay for and would have third party information and input about CytoDyn and Leronlimab (ie, could go get quotes from FDA and other medical officials, etc.).